Skip to main content

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

Jamp-Nystatin

Covered
  • Active ingredient(s):
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    Oral Suspension 100 000 U/mL DIN : 2433443

pms-Nystatin

Covered
  • Active ingredient(s):
  • Manufactured by:
    Pharmascience Inc. (Phmscience)
  • Strength and dosage form:
    Oral Suspension 100 000 U/mL DIN : 792667

Ocrevus

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Hoffmann-La Roche Ltée (Roche)
  • Strength and dosage form:
    Intravenous Perfusion Solution 30 mg/mL (10 mL) DIN : 2467224

Octreotide Acetate Omega

Covered
  • Active ingredient(s):
  • Manufactured by:
    Laboratoires Omega Ltée (Oméga)
  • Strength and dosage form:
    • Injectable Solution 100 mcg/mL DIN : 2248640
    • Injectable Solution 200 mcg/mL DIN : 2248642
    • Injectable Solution 50 mcg/mL DIN : 2248639

Sandostatin

Covered
  • Active ingredient(s):
  • Manufactured by:
    Novartis Pharma Canada Inc (Novartis)
  • Strength and dosage form:
    • Injectable Solution 100 mcg/mL DIN : 839205
    • Injectable Solution 50 mcg/mL DIN : 839191

Octréotide pour suspension injectable

Covered
  • Active ingredient(s):
  • Manufactured by:
    Teva Canada Ltée (Teva Can)
  • Strength and dosage form:
    • Intramuscular Injection Suspension 10 mg DIN : 2503751
    • Intramuscular Injection Suspension 20 mg DIN : 2503778
    • Intramuscular Injection Suspension 30 mg DIN : 2503786

Sandostatin LAR

Covered
  • Active ingredient(s):
  • Manufactured by:
    Novartis Pharma Canada Inc (Novartis)
  • Strength and dosage form:
    • Intramuscular Injection Suspension 10 mg DIN : 2239323
    • Intramuscular Injection Suspension 20 mg DIN : 2239324
    • Intramuscular Injection Suspension 30 mg DIN : 2239325

Kesimpta (pen)

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Novartis Pharma Canada Inc (Novartis)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 20 mg/0.4 mL DIN : 2511355

Ocuflox

Covered
  • Active ingredient(s):
  • Manufactured by:
    La Corporation AbbVie (AbbVie)
  • Strength and dosage form:
    Ophtalmic Solution 0.3 % DIN : 2143291

AG-Olanzapine FC

Covered
  • Active ingredient(s):
  • Manufactured by:
    Angita Pharma Inc. (Angita)
  • Strength and dosage form:
    • Tablet 10 mg DIN : 2487632
    • Tablet 2.5 mg DIN : 2487608
    • Tablet 5 mg DIN : 2487616

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.